HelioLiver LDT now available to order through Quest Diagnostics
Unite.AI and Helio Genomics: a physician reviews a transparent diagnostic display with a patient
News & Media

Unite.AI: Why Building Clinician and Patient Trust Is Healthcare’s Next Imperative

Media August 6, 2026 6 min read By Dr. Bharat Tewarie
Share

In a byline published by Unite.AI, Helio Genomics Chief Executive Officer Dr. Bharat Tewarie, MD, MBA, argues that the future of healthcare AI will be determined not by algorithms alone, but by how effectively organizations build the trust, transparency, and clinical confidence needed to put AI into practice.

Drawing on more than two decades of experience helping healthcare organizations integrate emerging technologies, Dr. Tewarie writes that innovation alone is not enough to change clinical practice. True medical breakthroughs happen only when clinicians trust new tools enough to incorporate them into decision-making, and when patients understand how those technologies support, rather than replace, clinical judgment. Artificial intelligence, he argues, has now reached that inflection point: its role has shifted from reducing administrative burden to serving as a practical clinical tool that helps clinicians identify disease earlier, personalize treatment decisions, and uncover patterns that might otherwise go undetected.

Trust Begins with Evidence

Clinicians adopt new methods of care only after they have been rigorously studied, and Dr. Tewarie argues that AI should be held to exactly the same standard as any new diagnostic tool or medication. That bar matters most in diagnostics, where AI has the potential to influence life-changing clinical decisions.

He points to the growing body of prospective clinical research evaluating these technologies under real-world conditions, including recent findings published in the Journal of Hepatology: among patients at high risk for hepatocellular carcinoma (HCC), a new AI-powered blood-based surveillance test had a sensitivity of 47.8% for all HCC lesions, compared with 28.3% for conventional ultrasound imaging. This kind of evidence, he writes, proves that new methods are not just safe but can deliver measurable value in patient outcomes. Read more about the trial behind those results on the CLiMB study page.

Integrating Algorithms into Workflow without Disruption

Clinical evidence is only one piece of the puzzle. Even the most accurate AI model will not scale if it cannot integrate into daily workflow or creates unnecessary friction. Clinicians carry personal and legal accountability for every decision, and under intense time pressure they default to familiar routines. Research on clinician adoption consistently highlights workflow disruption, lack of explainability, and diminished trust as barriers to implementation.

AI scales successfully, Dr. Tewarie writes, when organizations recognize that the technology needs to adapt to clinical practice, not the other way around.

Co-Designing AI to Earn Clinician and Patient Trust

Organizations that successfully implement AI tend to follow a set of common principles:

  • Design around clinical practice, not technology. AI needs to fit naturally within existing workflows and solve meaningful clinical problems.
  • Keep clinicians in the loop. Clinician oversight is essential for preserving clinical autonomy and building trust through real-world adoption.
  • Prioritize transparent patient communication. When clinicians can clearly explain how AI supported their judgment, patients are more likely to accept and trust their recommendations.
  • Measure real-world impact. Operational outcomes, governance, and real-world adoption matter as much as model performance.

The Path Forward

Strong technical performance, Dr. Tewarie concludes, is table stakes. The organizations that will lead healthcare AI’s next chapter are those that understand lasting adoption depends on building trust with both clinicians and patients, and that trust depends on seamless integration into existing clinical workflows.

“The organizations that lead will be the ones who recognize trust as healthcare AI’s true operating system, designing every tool, workflow, and governance model around the human realities of care.”

BTDr. Bharat Tewarie, MD, MBACEO, Helio Genomics

The future of healthcare AI, he writes, will not be won by algorithms developed in isolation. It will be shaped in the exam room, at the nursing station, and during the handoff, where technology must prove that it can strengthen judgment, preserve connection, and make care more trustworthy.

Read the Full Article

View source version on unite.ai.

Related Articles

More from Helio Genomics

MediaJuly 24, 2026

Life Science Daily: How Blood-Based Testing Could Close the Detection Gap

A byline by Helio CEO Dr. Bharat Tewarie on how blood-based testing could close the gap in liver cancer detection and surveillance.

Read more
MediaMay 6, 2026

OncoDaily: Bharat Tewarie on a Real Fighting Chance Against Liver Cancer

Helio’s CEO reflects on the landmark CLiMB study and what earlier liver cancer detection means for patients.

Read more
MediaMay 6, 2026

Journal of Hepatology Publishes Landmark HelioLiver CLiMB Study

Published in the Journal of Hepatology: HelioLiver detects more early HCC than ultrasound in cirrhosis (47.8% vs 28.3%; 28.6% vs 0% for lesions under 2 cm).

Read more